Innovaccer Inc., a leading healthcare AI company, has secured $275M in Series F funding, combining primary and secondary investments. The round saw participation from B Capital Group, Banner Health, Danaher Ventures, Generation Investment Management, Kaiser Permanente, and M12. This funding will support Innovaccer’s expansion in AI and cloud capabilities, further collaboration with existing clients, and the growth of a developer ecosystem. The company plans to introduce new tools, including copilots and agents for various healthcare functions like care management and clinical decision support.

Founded in 2014, Innovaccer offers a comprehensive suite of software solutions to enhance value-based care, modernize the patient experience, and reduce administrative burdens. It has earned Best-in-KLAS recognition for its excellence in categories like Data and Analytics, Population Health Management, and CRM.

Innovaccer’s CEO, Abhinav Shashank, emphasized the company's commitment to transforming healthcare with data-driven insights and AI technology. The company has seen significant growth, serving 6 of the top 10 health systems and expanding public sector partnerships. Its platform supports over 130 healthcare organizations and continues to lead in population health, data management, and AI, achieving 50% year-over-year revenue growth for the past five years.

Julie Sawyer Montgomery of Danaher Corporation expressed confidence in Innovaccer’s vision for AI in healthcare, highlighting the potential for faster, personalized care with better data and analytics. Innovaccer has now raised a total of $675M and recently acquired Cured and Pharmacy Quality Solutions.

Click here to read the original news story.